193 related articles for article (PubMed ID: 9550388)
1. Single amino acid mutations in the murine MHC class II A beta cytoplasmic domain abrogate antigen presentation.
Laufer TM; Smiley ST; Ranger A; Clements VK; Ostrand-Rosenberg S; Glimcher LH
J Immunol; 1997 Dec; 159(12):5914-20. PubMed ID: 9550388
[TBL] [Abstract][Full Text] [Related]
2. The extracellular domains of MHC class II molecules determine their processing requirements for antigen presentation.
Kjer-Nielsen L; Perera JD; Boyd LF; Margulies DH; McCluskey J
J Immunol; 1990 Apr; 144(8):2915-24. PubMed ID: 1969876
[TBL] [Abstract][Full Text] [Related]
3. Functional effects of N-linked oligosaccharides located on the external domain of murine class II molecules.
Wei BY; Buerstedde JM; Bell M; Chase C; Nilson A; Browne A; Pease L; McKean DJ
J Immunol; 1991 Apr; 146(7):2358-66. PubMed ID: 1706396
[TBL] [Abstract][Full Text] [Related]
4. Rejection of mouse sarcoma cells after transfection of MHC class II genes.
Ostrand-Rosenberg S; Thakur A; Clements V
J Immunol; 1990 May; 144(10):4068-71. PubMed ID: 2332639
[TBL] [Abstract][Full Text] [Related]
5. Rejection of K1735 murine melanoma in syngeneic hosts requires expression of MHC class I antigens and either class II antigens or IL-2.
Chen PW; Ananthaswamy HN
J Immunol; 1993 Jul; 151(1):244-55. PubMed ID: 8326126
[TBL] [Abstract][Full Text] [Related]
6. Antigen presentation abrogated in cells expressing truncated Ia molecules.
Nabavi N; Ghogawala Z; Myer A; Griffith IJ; Wade WF; Chen ZZ; McKean DJ; Glimcher LH
J Immunol; 1989 Mar; 142(5):1444-7. PubMed ID: 2918224
[TBL] [Abstract][Full Text] [Related]
7. Length and sequence requirements of the cytoplasmic domain of the A beta molecule for class II-mediated B cell signaling.
Harton JA; Bishop GA
J Immunol; 1993 Nov; 151(10):5282-9. PubMed ID: 8228224
[TBL] [Abstract][Full Text] [Related]
8. I-Ak polymorphisms define a functionally dominant region for the presentation of hen egg lysozyme peptides.
Rosloniec EF; Vitez LJ; Beck BN; Buerstedde JM; McKean DJ; Landais D; Benoist C; Mathis D; Freed JH
J Immunol; 1989 Jul; 143(1):50-8. PubMed ID: 2786533
[TBL] [Abstract][Full Text] [Related]
9. Abrogation of tumorigenicity by MHC class II antigen expression requires the cytoplasmic domain of the class II molecule.
Ostrand-Rosenberg S; Roby CA; Clements VK
J Immunol; 1991 Oct; 147(7):2419-22. PubMed ID: 1918972
[TBL] [Abstract][Full Text] [Related]
10. Presentation of antigens internalized through the B cell receptor requires newly synthesized MHC class II molecules.
Forquet F; Barois N; Machy P; Trucy J; Zimmermann VS; Leserman L; Davoust J
J Immunol; 1999 Mar; 162(6):3408-16. PubMed ID: 10092796
[TBL] [Abstract][Full Text] [Related]
11. Class II-restricted presentation of a hen egg lysozyme determinant derived from endogenous antigen sequestered in the cytoplasm or endoplasmic reticulum of the antigen presenting cells.
Brooks AG; McCluskey J
J Immunol; 1993 May; 150(9):3690-7. PubMed ID: 8473726
[TBL] [Abstract][Full Text] [Related]
12. The importance of dominant negative effects of amino acid side chain substitution in peptide-MHC molecule interactions and T cell recognition.
Boehncke WH; Takeshita T; Pendleton CD; Houghten RA; Sadegh-Nasseri S; Racioppi L; Berzofsky JA; Germain RN
J Immunol; 1993 Jan; 150(2):331-41. PubMed ID: 8093457
[TBL] [Abstract][Full Text] [Related]
13. Rejection of MHC class II-transfected tumor cells requires induction of tumor-encoded B7-1 and/or B7-2 costimulatory molecules.
Baskar S; Clements VK; Glimcher LH; Nabavi N; Ostrand-Rosenberg S
J Immunol; 1996 May; 156(10):3821-7. PubMed ID: 8621919
[TBL] [Abstract][Full Text] [Related]
14. Polarized transport of MHC class II molecules in Madin-Darby canine kidney cells is directed by a leucine-based signal in the cytoplasmic tail of the beta-chain.
Simonsen A; Pedersen KW; Nordeng TW; von der Lippe A; Stang E; Long EO; Bakke O
J Immunol; 1999 Sep; 163(5):2540-8. PubMed ID: 10452991
[TBL] [Abstract][Full Text] [Related]
15. Arsonate-specific murine T cell clones. V. Antigen presentation by L cells transfected with normal and mutant class II genes.
Norton FL; Davis CB; Jones PP; Goodman JW
J Immunol; 1989 Jul; 143(2):446-51. PubMed ID: 2472438
[TBL] [Abstract][Full Text] [Related]
16. Polymorphism in the beta chain of IAq versus IAp influences presentation of protein but not peptide antigens.
Lambert LE; Berling JS; Thompson SD; Harton JA; Bishop GA; Choi E
Cell Immunol; 1995 Oct; 165(2):202-10. PubMed ID: 7553884
[TBL] [Abstract][Full Text] [Related]
17. Replacement of N-glycosylation sites on the MHC class II E alpha chain. Effect on thymic selection and peripheral T cell activation.
Ishikawa S; Kowal C; Cole B; Thomson C; Diamond B
J Immunol; 1995 May; 154(10):5023-9. PubMed ID: 7730609
[TBL] [Abstract][Full Text] [Related]
18. A site for CD4 binding in the beta 1 domain of the MHC class II protein HLA-DR1.
Brogdon J; Eckels DD; Davies C; White S; Doyle C
J Immunol; 1998 Nov; 161(10):5472-80. PubMed ID: 9820523
[TBL] [Abstract][Full Text] [Related]
19. [Analysis of the allele specific Ag-binding site on murine class II MHC].
Kajino K
Hokkaido Igaku Zasshi; 1996 Mar; 71(2):187-203. PubMed ID: 8641675
[TBL] [Abstract][Full Text] [Related]
20. Cell surface expression of hybrid murine/human MHC class II beta alpha dimers. Key influence of residues in the amino-terminal portion of the beta 1 domain.
Lechler RI; Sant AJ; Braunstein NS; Sekaly R; Long E; Germain RN
J Immunol; 1990 Jan; 144(1):329-33. PubMed ID: 2404065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
